SMTL ID : 6h5w.1

Crystal structure of human Angiotensin-1 converting enzyme C-domain in complex with Omapatrilat.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.37 Å

Oligo State

monomer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 6 residues within 4Å: Chain A: N.36, T.38, E.40, T.41, D.310, R.312 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.40

1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-FUC.2: 9 residues within 4Å: Chain A: S.9, V.12, E.13, N.73, T.75, I.76, L.361, P.362, L.365 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:V.12, A:I.76 Hydrogen bonds: A:E.13, A:E.13

1 x ZN: ZINC ION(Non-covalent)

ZN.3: 6 residues within 4Å: Chain A: H.347, H.351, E.375, Y.487 Ligands: FT8.6, EDO.19 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.347, A:H.351, A:E.375

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.4: 6 residues within 4Å: Chain A: W.146, R.150, W.449, W.450, R.453, D.471 Ligand excluded by PLIP CL.5: 5 residues within 4Å: Chain A: Y.188, P.371, P.483, I.485, R.486 Ligand excluded by PLIP

3 x FT8: Omapatrilat(Non-covalent)

FT8.6: 23 residues within 4Å: Chain A: Q.245, H.317, A.318, S.319, A.320, V.344, H.347, E.348, H.351, E.375, F.421, K.475, F.476, H.477, V.482, Y.484, Y.487, F.491 Ligands: ZN.3, FT8.7, FT8.8, BO3.10, EDO.19 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:A.318, A:F.421, A:F.476, A:Y.487 Hydrogen bonds: A:Q.245, A:H.317, A:A.318, A:H.477, A:Y.484, A:Y.484, A:Y.487 Water bridges: A:K.475, A:K.475 Salt bridges: A:H.317, A:K.475, A:H.477 FT8.7: 21 residues within 4Å: Chain A: D.85, E.87, R.88, Y.177, S.183, W.184, S.186, M.187, Y.324, F.355, Y.358, R.366, E.367, H.374, V.482, P.483, R.486 Ligands: FT8.6, FT8.8, EDO.15, EDO.19 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:E.367 Hydrogen bonds: A:R.486, A:R.486 Water bridges: A:R.88, A:W.184 Salt bridges: A:R.88 FT8.8: 19 residues within 4Å: Chain A: Y.26, N.30, N.34, N.49, I.52, E.87, R.88, Y.99, N.100, L.103, E.107, W.321, S.480, S.481, V.482, P.483, R.486 Ligands: FT8.6, FT8.7 5 PLIP interactions: 5 interactions with chain A Water bridges: A:Y.26, A:N.49, A:R.88, A:S.481 Salt bridges: A:R.88

1 x IMD: IMIDAZOLE(Non-covalent)

IMD.9: 8 residues within 4Å: Chain A: E.147, D.151, R.155, V.463, P.464, R.465, T.466, D.469 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.465, A:R.465, A:T.466, A:D.469 Water bridges: A:E.147, A:D.151

3 x BO3: BORIC ACID(Non-covalent)

BO3.10: 7 residues within 4Å: Chain A: V.343, H.347, D.379, D.417, K.418, F.491 Ligands: FT8.6 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.379, A:K.418 BO3.11: 10 residues within 4Å: Chain A: Y.251, S.262, P.388, L.397, E.400, H.406, N.409, F.410, K.413 Ligands: P6G.13 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Y.251, A:H.406 Water bridges: A:Y.251, A:E.400, A:E.400 BO3.12: 4 residues within 4Å: Chain A: F.257, D.404, I.408, W.566 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.404 Water bridges: A:W.566

1 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)

P6G.13: 16 residues within 4Å: Chain A: S.248, N.249, Y.251, S.262, D.264, T.265, T.266, L.339, V.343, S.386, L.391, L.397, F.410, K.413, M.414 Ligands: BO3.11 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.413 Water bridges: A:T.265

6 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.14: 4 residues within 4Å: Chain A: V.112, A.113, T.114, K.152 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:V.112, A:T.114, A:K.152 EDO.15: 10 residues within 4Å: Chain A: D.85, E.87, R.88, I.168, A.171, A.172, N.175, Y.177, S.183 Ligands: FT8.7 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.88, A:N.175, A:S.183 EDO.16: 8 residues within 4Å: Chain A: Y.33, I.37, T.38, T.39, S.42, L.104, T.108 Ligands: EDO.17 No protein-ligand interaction detected (PLIP) EDO.17: 7 residues within 4Å: Chain A: L.104, D.105, T.108, T.109, V.112, F.160 Ligands: EDO.16 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:D.105 EDO.18: 3 residues within 4Å: Chain A: R.568, T.569, E.572 2 PLIP interactions: 2 interactions with chain A Water bridges: A:T.569, A:E.572 EDO.19: 8 residues within 4Å: Chain A: A.320, H.351, F.355, H.374, E.375 Ligands: ZN.3, FT8.6, FT8.7 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.351

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cozier, G.E. et al., Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design. J. Med. Chem. (2018)

Release Date

2018-11-07

Peptides

Angiotensin-converting enzyme: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Angiotensin-converting enzyme

Related Entries With Identical Sequence